2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride has been researched along with 1,2-bis(5-amidino-2-benzimidazolyl)ethane in 1 studies
Studies (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Trials (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Recent Studies (post-2010) (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Studies (1,2-bis(5-amidino-2-benzimidazolyl)ethane) | Trials (1,2-bis(5-amidino-2-benzimidazolyl)ethane) | Recent Studies (post-2010) (1,2-bis(5-amidino-2-benzimidazolyl)ethane) |
---|---|---|---|---|---|
10 | 0 | 0 | 6 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bing, DH; Falk, RJ; Geratz, JD; Jennette, JC; Tidwell, RR | 1 |
1 other study(ies) available for 2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride and 1,2-bis(5-amidino-2-benzimidazolyl)ethane
Article | Year |
---|---|
Amelioration of immune complex-mediated glomerulonephritis by synthetic protease inhibitors.
Topics: Amidines; Animals; Benzimidazoles; Complement Inactivator Proteins; Creatinine; Glomerulonephritis; Hydroxamic Acids; Immune Complex Diseases; Indoles; Male; Mice; Protease Inhibitors; Time Factors; Trypsin Inhibitors | 1987 |